[Anesthesiologic management of the patient threatened by malignant hyperthermia].
作者信息
Scholtes J L, Gribomont B F
出版信息
Cah Anesthesiol. 1985 Mar;33(2):159-60.
PMID:3995397
Abstract
摘要
相似文献
1
[Anesthesiologic management of the patient threatened by malignant hyperthermia].
Cah Anesthesiol. 1985 Mar;33(2):159-60.
2
Malignant hyperthermia in a liver transplant patient: a case report.肝移植患者的恶性高热：一例报告
Transplant Proc. 2007 Dec;39(10):3530-2. doi: 10.1016/j.transproceed.2007.09.036.
3
Be prepared: malignant hyperthermia.做好准备：恶性高热。
OR Manager. 2008 Jun;24(6):26-7, 30.
4
Malignant hyperthermia in the otology patient: the UCLA experience.耳科患者的恶性高热：加州大学洛杉矶分校的经验
Am J Otol. 1994 May;15(3):371-5.
5
6
Rapid intervention for an episode of malignant hyperthermia.对恶性高热发作的快速干预。
Can J Anaesth. 2003 Feb;50(2):104-7. doi: 10.1007/BF03017839.
7
Malignant hyperthermia in the absence of triggering agents.无触发因素时的恶性高热。
Anesth Analg. 2010 Sep;111(3):822; author reply 822-3. doi: 10.1213/ANE.0b013e3181e9e5f2.
8
Prophylactic use of dantrolene in a patient with central core disease.
Anesth Analg. 1998 Apr;86(4):915-6. doi: 10.1097/00000539-199804000-00047.
9
Mixing and using dantrolene for simulated malignant hyperthermia crisis.混合并使用丹曲林治疗模拟恶性高热危象。
Acta Anaesthesiol Scand. 2012 Nov;56(10):1337-8. doi: 10.1111/j.1399-6576.2012.02751.x. Epub 2012 Aug 10.
10
Dantrolene sodium in the management of patients at risk from malignant hyperthermia.丹曲林钠用于管理恶性高热风险患者。
J Oral Surg. 1979 Oct;37(10):719-24.
Zotero 插件